Form 4/A for MLAB MESA LABORATORIES INC /CO/
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001228924-22-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2022-08-17 | 2022-08-15+ | MLAB | Sakys John | CFO | S - Sale+OE | $200.57 | -744 | 8,678 | -8% | -$149.2K |
| DMA | 2022-08-17 | 2022-08-15+ | MLAB | Sakys John | CFO | M - OptEx | $70.56 | +2,000 | 10.7K | +23% | +$141.1K |
| DMA | 2022-08-17 | 2022-08-15+ | MLAB | Sakys John | CFO | X - OptEx | $0.00 | -2,000 | 31.2K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-15 | S | A | 628 | $200.54 | 10,050 | D | — | — | (F2) Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on June 14, 2022 |
| 2 | Common | Common Stock | 2022-08-15 | M | A | 628 | $70.56 | 9,306 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-16 | M | A | 1,372 | $70.56 | 10,678 | D | — | — | |
| 4 | Common | Common Stock | 2022-08-16 | S | D | 1,372 | $200.58 | 8,678 | D | — | — | (F2) Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on June 14, 2022 |
| 5 | Derivative | Non Qualified Stock Option | 2022-08-16 | X | D | 1,372 | $0.00 | 29,802 | D | $70.56 · 2016-04-01 to 2023-04-01 | 1,372 Common Stock | (F1) 1/7 exercisable on each anniversary of the 04/01/2015 grant date |
| 6 | Derivative | Non Qualified Stock Option | 2022-08-15 | X | D | 628 | $0.00 | 31,174 | D | $70.56 · 2016-04-01 to 2023-04-01 | 628 Common Stock | (F1) 1/7 exercisable on each anniversary of the 04/01/2015 grant date |